PLX51107
- Generic Name
- PLX51107
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C26H22N4O3
- CAS Number
- 1627929-55-8
- Unique Ingredient Identifier
- W758F1L9ND
- Background
PLX51107 is a potent and selective inhibitor of the bromodomain and extraterminal (BET) protein family. PLX51107 is under investigation in clinical trial NCT04022785 (PLX51107 and Azacitidine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome).
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath